-+ 0.00%
-+ 0.00%
-+ 0.00%

Pfizer Reports TUKYSA Combo Extends Progression-Free Survival in HER2+ Metastatic Breast Cancer

路透·12/10/2025 13:15:21

登錄查看新聞詳情